Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
Medicare and Medicaid are major sources of government spending, yet Democrats and Republicans alike support funding the ...
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...
U.S. Health and Human Services Secretary Xavier Becerra says “this is a big deal.” Drug companies oppose the program.
Alignment Healthcare (NASDAQ:ALHC) has taken the Centers for Medicare & Medicaid Services (CMS) to court over the accuracy of ...
EnforceMintz — Medicare Advantage and Part D Programs to Remain in the Enforcement Spotlight in 2025
As government scrutiny and enforcement targeting the Medicare Advantage (Medicare Part C) program continued in 2024, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback